Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,251 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Executive summary: British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.
Price EJ, Benjamin S, Bombardieri M, Bowman S, Carty S, Ciurtin C, Crampton B, Dawson A, Fisher BA, Giles I, Glennon P, Gupta M, Hackett KL, Larkin G, Ng WF, Ramanan AV, Rassam S, Rauz S, Smith G, Sutcliffe N, Tappuni A, Walsh SB. Price EJ, et al. Among authors: smith g. Rheumatology (Oxford). 2024 May 24:keae218. doi: 10.1093/rheumatology/keae218. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38785300 No abstract available.
Carbapenem-Resistant and Extended-Spectrum β-Lactamase-Producing Enterobacterales in Children, United States, 2016-2020.
Grome HN, Grass JE, Duffy N, Bulens SN, Ansari U, Campbell D, Lutgring JD, Gargis AS, Masters T, Kent AG, McKay SL, Smith G, Wilson LE, Vaeth E, Evenson B, Dumyati G, Tsay R, Phipps E, Flores K, Wilson CD, Czaja CA, Johnston H, Janelle SJ, Lynfield R, O'Malley S, Vagnone PS, Maloney M, Nadle J, Guh AY. Grome HN, et al. Among authors: smith g. Emerg Infect Dis. 2024 Jun;30(6):1104-1114. doi: 10.3201/eid3006.231734. Emerg Infect Dis. 2024. PMID: 38781979 No abstract available.
A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic actions: Preclinical and phase I study.
Kaneko N, Loughrey CM, Smith G, Matsuda R, Hasunuma T, Mark PB, Toda M, Shinozaki M, Otani N, Kayley S, Da Silva Costa A, Martin TP, Dobi S, Saxena P, Shimamoto K, Ishikawa T, Kambayashi R, Riddell A, Elliott EB, McCarroll CS, Sakai T, Mitsuhisa Y, Hirano S, Kitai T, Kusano K, Inoue Y, Nakamura M, Kikuchi M, Toyoda S, Taguchi I, Fujiwara T, Sugiyama A, Kumagai Y, Iwata K. Kaneko N, et al. Among authors: smith g. Br J Pharmacol. 2024 May 21. doi: 10.1111/bph.16379. Online ahead of print. Br J Pharmacol. 2024. PMID: 38773354
Doppler ultrasound surveillance of recently formed haemodialysis arteriovenous fistula: the SONAR observational cohort study.
Richards J, Summers D, Sidders A, Allen E, Ayaz Hossain M, Paul S, Slater M, Bartlett M, Lagaac R, Laing E, Hopkins V, Fitzpatrick-Creamer C, Hudson C, Parsons J, Turner S, Tambyraja A, Somalanka S, Hunter J, Dutta S, Hoye N, Lawman S, Salter T, Aslam MF, Bagul A, Sivaprakasam R, Smith GE, Thomas HL, Moinuddin Z, Knight SR, Barnett N, Motallebzadeh R, Pettigrew GJ; SONAR trial group. Richards J, et al. Among authors: smith ge. Health Technol Assess. 2024 May;28(24):1-54. doi: 10.3310/YTBT4172. Health Technol Assess. 2024. PMID: 38768043 Free article.
Early Ultrasound Surveillance of Newly-Created Hemodialysis Arteriovenous Fistula.
Richards J, Summers D, Sidders A, Allen E, Thomas H, Hossain MA, Paul S, Slater M, Bartlett M, Lagaac R, Laing E, Hopkins V, Fitzpatrick-Creamer C, Hudson C, Parsons J, Turner S, Tambyraja A, Somalanka S, Hunter J, Dutta S, Hoye N, Lawman S, Salter T, Aslam M, Bagul A, Sivaprakasam R, Smith G, Moinuddin Z, Knight S, Barnett N, Motallebzadeh R, Pettigrew GJ; SONAR trial group. Richards J, et al. Among authors: smith g. Kidney Int Rep. 2024 Jan 5;9(4):1005-1019. doi: 10.1016/j.ekir.2024.01.011. eCollection 2024 Apr. Kidney Int Rep. 2024. PMID: 38765580 Free PMC article.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Parker CC, Clarke NW, Cook AD, Kynaston H, Catton CN, Cross WR, Petersen PM, Persad RA, Saad F, Bower LC, Logue J, Payne H, Forcat S, Goldstein C, Murphy C, Anderson J, Barkati M, Bottomley DM, Branagan J, Choudhury A, Chung PWM, Cogley L, Goh CL, Hoskin P, Khoo V, Malone SC, Masters L, Morris SL, Nabid A, Ong AD, Raman R, Tarver KL, Tree AC, Worlding J, Wylie JP, Zarkar AM, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 May 16:S0140-6736(24)00548-8. doi: 10.1016/S0140-6736(24)00548-8. Online ahead of print. Lancet. 2024. PMID: 38763154 Free article.
15,251 results
You have reached the last available page of results. Please see the User Guide for more information.